Where Data Tells the Story
© Voronoi 2026. All rights reserved.
On November 21, 2025, Eli Lilly’s market value hit $1.0 trillion, a historic first for any pharmaceutical company. The surge was driven by soaring global demand for Mounjaro and Zepbound, stronger revenue guidance, and growing optimism around its oral GLP-1 drug, orforglipron.